Finding hidden treasures in old drugs: the challenges and importance of licensing generics

Research output: Contribution to journalShort surveyAcademicpeer-review

Abstract

Identifying new indications for existing drugs creates new therapeutic options while bypassing much of the costs and time involved with bringing a new drug to market. The rediscovery of a generic drug, however, is a challenging pursuit because there is no formal regulatory approach and a lack of economic interest by pharmaceutical companies. This played a part in the re-registration of thioguanine as a rescue drug for the treatment of patients with inflammatory bowel disease in The Netherlands. In this article, we aim to underline the importance of drug rediscovery, the difficulties of this procedure in Europe and we attempt to suggest conceivable solutions.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalDrug Discovery Today
Volume23
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Cite this

@article{d05386b674144c6281c4159c2e86784f,
title = "Finding hidden treasures in old drugs: the challenges and importance of licensing generics",
abstract = "Identifying new indications for existing drugs creates new therapeutic options while bypassing much of the costs and time involved with bringing a new drug to market. The rediscovery of a generic drug, however, is a challenging pursuit because there is no formal regulatory approach and a lack of economic interest by pharmaceutical companies. This played a part in the re-registration of thioguanine as a rescue drug for the treatment of patients with inflammatory bowel disease in The Netherlands. In this article, we aim to underline the importance of drug rediscovery, the difficulties of this procedure in Europe and we attempt to suggest conceivable solutions.",
author = "Melek Simsek and Berrie Meijer and {van Bodegraven}, {Adriaan A.} and {de Boer}, {Nanne K.H.} and Mulder, {Chris J.J.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.drudis.2017.08.008",
language = "English",
volume = "23",
pages = "17--21",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "1",

}

Finding hidden treasures in old drugs : the challenges and importance of licensing generics. / Simsek, Melek; Meijer, Berrie; van Bodegraven, Adriaan A.; de Boer, Nanne K.H.; Mulder, Chris J.J.

In: Drug Discovery Today, Vol. 23, No. 1, 01.01.2018, p. 17-21.

Research output: Contribution to journalShort surveyAcademicpeer-review

TY - JOUR

T1 - Finding hidden treasures in old drugs

T2 - the challenges and importance of licensing generics

AU - Simsek, Melek

AU - Meijer, Berrie

AU - van Bodegraven, Adriaan A.

AU - de Boer, Nanne K.H.

AU - Mulder, Chris J.J.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Identifying new indications for existing drugs creates new therapeutic options while bypassing much of the costs and time involved with bringing a new drug to market. The rediscovery of a generic drug, however, is a challenging pursuit because there is no formal regulatory approach and a lack of economic interest by pharmaceutical companies. This played a part in the re-registration of thioguanine as a rescue drug for the treatment of patients with inflammatory bowel disease in The Netherlands. In this article, we aim to underline the importance of drug rediscovery, the difficulties of this procedure in Europe and we attempt to suggest conceivable solutions.

AB - Identifying new indications for existing drugs creates new therapeutic options while bypassing much of the costs and time involved with bringing a new drug to market. The rediscovery of a generic drug, however, is a challenging pursuit because there is no formal regulatory approach and a lack of economic interest by pharmaceutical companies. This played a part in the re-registration of thioguanine as a rescue drug for the treatment of patients with inflammatory bowel disease in The Netherlands. In this article, we aim to underline the importance of drug rediscovery, the difficulties of this procedure in Europe and we attempt to suggest conceivable solutions.

UR - http://www.scopus.com/inward/record.url?scp=85040285788&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2017.08.008

DO - 10.1016/j.drudis.2017.08.008

M3 - Short survey

VL - 23

SP - 17

EP - 21

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 1

ER -